Gardasil 9

Valsts: Norvēģija

Valoda: norvēģu

Klimata pārmaiņas: Statens legemiddelverk

Aktīvā sastāvdaļa:

Humant papillomavirus, type 6 L1 protein, rekombinant / Humant papillomavirus, type 11 L1 protein, rekombinant / Humant papillomavirus, type 16 L1 protein, rekombinant / Humant papillomavirus, type 18 L1 protein, rekombinant / Humant papillomavirus, type 31 L1 protein, rekombinant / Humant papillomavirus, type 33 L1 protein, rekombinant / Humant papillomavirus, type 45 L1 protein, rekombinant / Humant papillomavirus, type 52 L1 protein, rekombinant / Humant papillomavirus, type 58 L1 protein, rekombinant

Pieejams no:

Orifarm AS

ATĶ kods:

J07BM03

SNN (starptautisko nepatentēto nosaukumu):

Humant papillomavirus, type 6 L1 protein, rekombinant / Humant papillomavirus, type 11 L1 protein, rekombinant / Humant papillomavirus, type 16 L1 protein, rekombinant / Humant papillomavirus, type 18 L1 protein, rekombinant / Humant papillomavirus, type 31 L1 protein, rekombinant / Humant papillomavirus, type 33 L1 protein, rekombinant / Humant papillomavirus, type 45 L1 protein, rekombinant / Humant papillomavirus, type 52 L1 protein, rekombinant / Humant papillomavirus, type 58 L1 protein, rekombinant

Zāļu forma:

Injeksjonsvæske, suspensjon

Vienības iepakojumā:

Ferdigfylt sprøyte 1x0.5 ml

Receptes veids:

C

Autorizācija statuss:

Markedsført

Autorizācija datums:

2022-04-01